Search Results 371-380 of 17738 for Papillary

  1. Breast cancer - Doctors and departments - Mayo Clinic

    ... Papillary breast cancer, Fibroadenoma, Luminal B breast cancer, Luminal A breast cancer, Squamous cell carcinoma of the breast, Triple-negative breast ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Papillary breast cancer, Fibroadenoma, Luminal B breast cancer, Luminal A breast cancer, Squamous cell carcinoma of the breast, Triple-negative breast ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Papillary breast cancer, Fibroadenoma, Luminal B breast cancer, Luminal A breast cancer, Squamous cell carcinoma of the breast, Triple-negative breast ...

  4. Publications - James W. Jakub, M.D. - Mayo Clinic

    Rare Presentation of Papillary Carcinoma Within a Sentinel Lymph Node in a Patient With Ductal Carcinoma in Situ of the Breast: A Challenging but Useful ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    ... Papillary breast cancer, Fibroadenoma, Luminal B breast cancer, Luminal A breast cancer, Squamous cell carcinoma of the breast, Triple-negative breast ...

  6. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Papillary breast cancer, Mucinous breast cancer, Stage 4 breast cancer, BRCA gene mutation, Paget's disease of the nipple, Atypical lobular hyperplasia ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Papillary breast cancer, Fibroadenoma, Luminal B breast cancer, Luminal A breast cancer, Squamous cell carcinoma of the breast, Triple-negative breast ...

  8. S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer - Mayo Clinic

    Patients must have had all grossly visible papillary tumors removed within 30 days prior to registration or cystoscopy confirming no grossly visible papillary ...

  9. A Study to Evaluate the Development of Patient Derived Xenografts in Patients With Breast Cancer - Mayo Clinic

    Exceptions for non-melanoma skin cancer, papillary thyroid cancer, non-invasive cancer (e.g., carcinoma in situ of the cervix). Eligibility last updated 7 ...

  10. A Study of Selpercatinib to Treat Participants with RET-Mutant Medullary Thyroid Cancer - Mayo Clinic

    Patients with mixed histology (e.g., incidental papillary thyroid cancer identified at the time of resection) are eligible if MTC is the dominant histology.